Calendar Faron Pharmaceuticals Oy

Equities

FARN

FI4000153309

Delayed London S.E. 04:26:07 2024-03-28 am EDT 5-day change 1st Jan Change
135 GBX -3.57% Intraday chart for Faron Pharmaceuticals Oy -8.78% -55.74%

Chart calendar Faron Pharmaceuticals Oy

30297a7.hoqJdhtu-FB8eH170qaDuU01dWBpF4SNBy2FaD0fGVE.9-nqEG4ZsjQNIQ0cm-768SpfWBokUdbGanXUHl5Qdz_FzsFbXzSZYSofNA~1f87e379c97eac4465b084c14cf5a355

Upcoming events on Faron Pharmaceuticals Oy

2024-04-05 03:00 am Annual General Meeting
2024-08-26 Q2 2024 Earnings Release
2025-03-20 Q4 2024 Earnings Release (Projected)
2025-09-23 Q2 2025 Earnings Release (Projected)
2026-03-19 Q4 2025 Earnings Release (Projected)
2026-09-29 Q2 2026 Earnings Release (Projected)

Past events on Faron Pharmaceuticals Oy

2024-03-19 05:00 am BEXMAB Phase I Study Results Call
2024-03-13 08:00 am Q4 2023 Earnings Call
2024-03-13 03:00 am Q4 2023 Earnings Release
2024-03-05 Carnegie Healthcare Conference
2024-01-24 Proactive One2One Investor Forum
2024-01-11 03:00 pm JPMorgan Healthcare Conference
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No: 2915
2023-10-11 08:00 am BEXMAB Phase I/II Study Results Call
2023-09-22 02:00 am Extraordinary Shareholders Meeting
2023-09-12 10:30 am H.C. Wainwright Global Investment Conference
2023-08-29 08:00 am Q2 2023 Earnings Call
2023-08-29 12:01 am Q2 2023 Earnings Release
2023-08-10 12:30 pm Canaccord Genuity Growth Conference
2023-07-19 08:30 am BEXMAB Phase I/II Study Results Call
2023-06-09 06:00 pm European Hematology Association Hybrid Congress - Poster No: P542
2023-06-07 European Hematology Association Hybrid Congress
2023-06-01 American Society for Clinical Oncology Meeting
2023-04-20 08:00 am Canaccord Genuity Horizons in Oncology Virtual Conference
2023-04-18 09:00 am American Association for Cancer Research Meeting - Abstract ID Section 37 Board 9
2023-04-17 09:00 am American Association for Cancer Research Meeting - Abstract ID Section 43 Board 16

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million EUR
Released
Forecast
Spread
0,02
0,02
-5%
0,00
0,00
-
0,00
0,00
-
0,00
2,90
-
0,00
0,00
-
0,00
0,00
-
EBITDA
Million EUR
Released
Forecast
Spread
-19,9
-18,4
-8.09%
-12,9
-6,90
-86.42%
-16,4
-12,9
-26.91%
-20,8
-19,4
-7.22%
-27,1
-27,4
1%
-28,2
-27,4
-3.11%
EBIT
Million EUR
Released
Forecast
Spread
0,00
0,00
-
-13,1
-7,31
-79.22%
-16,7
-14,0
-18.96%
-21,1
-18,2
-15.98%
-27,4
-25,2
-8.69%
-28,6
-27,7
-3.32%
Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
0,00
0,00
-
-13,3
-7,30
-81.52%
-16,9
-14,2
-19.27%
-21,2
-16,8
-26.06%
-28,7
-25,7
-11.94%
-30,9
-29,2
-5.88%
Net income
Million EUR
Released
Forecast
Spread
0,00
0,00
-
-13,3
-7,30
-81.67%
-16,9
-14,2
-19.34%
-21,2
-16,8
-26.15%
-28,7
-27,4
-5.05%
-30,9
-29,2
-5.88%
EPS
EUR
Released
Forecast
Spread
-0,65
0,00
-
-0,31
-0,21
-47.62%
-0,37
-0,30
-23.33%
-0,42
-0,35
-20.74%
-0,52
-0,50
-4.83%
0,00
-0,31
-
Announcement Date07/05/1920/03/2025/03/2125/03/2203/03/2313/03/24

Quarterly results

Fiscal PeriodDecember 2019 S1 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales
Million EUR
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBITDA
Million EUR
Released
Forecast
Spread
-6,30
-3,56
-76.83%
-6,57
-3,38
-94.32%
-7,02
-5,36
-30.88%
-9,36
-6,70
-39.64%
-10,3
-7,50
-37.09%



-13,2
-12,9
-2.43%
-13,9


-12,6


-15,6
-14,7
-6.38%

-13,9


-15,7







EBIT
Million EUR
Released
Forecast
Spread
-6,34
-3,71
-70.97%
-6,76
-3,60
-87.72%
-7,15
-5,51
-29.67%
-9,51
-6,80
-39.84%
-10,4
-7,70
-35.38%
-10,7
-6,30
-69.59%
-13,4
-12,2
-9.54%
-14,1
-10,7
-32.04%
-12,8
-13,8
6.82%
-15,8
-14,7
-6.94%

-14,1


-15,9







Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-6,41
-3,70
-73.27%
-6,84
-3,60
-90%
-7,34
-5,49
-33.75%
-9,59
-6,80
-41.07%
-10,6
-7,70
-37.06%
-10,6
-6,30
-68.65%
-13,1
-12,3
-6.96%
-15,6
-11,4
-37.09%
-13,7
-14,4
4.32%
-17,2
-15,8
-8.95%

-15,3


-17,2







Net income
Million EUR
Released
Forecast
Spread
-6,41
-3,70
-73.3%
-6,85
-3,60
-90.28%
-7,34
-5,49
-33.75%
-9,60
-6,80
-41.22%
-10,6
-7,70
-37.14%
-10,6
-6,30
-68.79%
-13,1
-12,3
-7.11%
-15,6
-13,6
-14.77%
-13,7
-15,6
11.99%
-17,2
-15,8
-8.95%

-15,3


-17,2







EPS
EUR
Released
Forecast
Spread
-0,17
-0,11
-54.55%
-0,16
-0,10
-60%
-0,16
-0,14
-14.29%
-0,22
-0,10
-120%
-0,21
-0,20
-5%
-0,21
-0,10
-110%
-0,25
-0,20
-25%
-0,27
-0,20
-35%
-0,22
-0,30
26.67%

-0,21


-0,21


-0,21







Announcement Date23/09/1920/03/2024/09/2025/03/2126/08/2125/03/2225/08/2203/03/2329/08/2313/03/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise